Becton Dickinson’s Rapid Antigen Test for COVID-19 Authorized by FDA, Shares Rise

The U.S. Food and Drug Administration has granted emergency use authorization to Becton Dickinson and Co for a COVID-19 antigen test that can be administered at the point of care and produce results within 15 minutes, the company said on Monday.

Read the full article here

Related Articles